SAN DIEGO--(BUSINESS WIRE)--Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, today announced that the first subject was dosed in the Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results